Dr. Alexis Thompson Discusses Early Successes of Gene Therapy for Sickle Cell Disease

Published on

Alexis Thompson headshot Sickle cell disease is a group of inherited blood disorders characterized by chronic anemia, episodes of pain, and other serious complications, including stroke. Researchers, including those at Children’s Hospital of Philadelphia, have been investigating the use of gene therapy to treat the condition, giving those living with sickle cell disease much hope. In this short documentary by the New England Journal of Medicine, Dr. Alexis Thompson, our Chief of Hematology, discusses the early successes of gene therapy, as well as its risks and benefits.

Contact: Jennifer Lee, The Children’s Hospital of Philadelphia, 267-426-6084 or leej41@chop.edu

Next Steps